Your Article Summary
See Latest ArticlesProteomic analysis to identify cytokeratin 18 as a novel biomarker of nasopharyngeal carcinoma
Journal of Cancer Research & Clinical Oncology, 06/22/09
Li X-M et al. - In a study to identify novel nasopharyngeal carcinoma (NPC) biomarkers, data suggest that cytokeratin 18 is a potential biomarker for differentiation and prognosis of NPC, and its dysregulation might play an important role in the pathogenesis of NPC.
Methods- Proteins from pooled microdissected NPC and normal nasopharyngeal epithelial tissues (NNET) were separated by 2-dimensional gel electrophoresis, and differential proteins were identified by mass spectrometry.
- Expression of the differential protein cytokeratin 18 in the above 2 tissues as well as 4 NPC cell lines was determined by Western blotting.
- Immunohistochemistry was performed to detect expression of cytokeratin 18 in 62 cases of primary NPC, 28 cases of NNET, and 20 cases of cervical lymph node metastases, and the correlation of its expression level with clinicopathologic features and clinical outcomes were evaluated.
- siRNA and in vitro cell invasion assay were used to check the correlation between expression of cytokeratin 18 and invasive ability of NPC.
- 36 differential proteins between the NPC and NNET were identified.
- Expression level of cytokeratin 18 in the 2 types of tissues was confirmed by Western blotting and related to differentiation degree and metastatic potential of the NPC cell lines.
- Significant cytokeratin 18 down-regulation was observed in NPC vs NNET, whereas significant cytokeratin 18 up-regulation was observed in lymph node metastasis vs primary NPC.
- Cytokeratin 18 down-regulation was significantly correlated with poor histological differentiation, whereas cytokeratin 18 up-regulation was significantly correlated with advanced clinical stage, recurrence, and regional lymph node metastasis, and distant metastasis.
- Down-regulated cytokeratin 18 expression by siRNA significantly decreased in vitro invasive ability of 5-8F cells.
- Survival curves showed that pts with cytokeratin 18 up-regulation had a poor prognosis.
- Univariate analysis showed that WHO histologic type, lymph node metastasis, distant metastasis, recurrence, and cytokeratin 18 were significantly associated with prognosis of NPC.
- Multivariate analysis confirmed that lymph node metastasis, distant metastasis, recurrence, and cytokeratin 18 were independent prognostic indicators.
Related Articles
Secondary prevention of acute kidney injury
Current Opinion in Critical Care, 11/19/09
Relevance Score: 67%
Novel Biomarkers for Prostate Cancer Including Noncoding Transcripts
American Journal of Pathology, 11/09/09
Relevance Score: 66%
iTRAQ-based proteomic identification of leucine rich alpha 2 glycoprotein (LRG) as a novel inflammatory biomarker in autoimmune diseases
Annals of Rheumatic Diseases, 11/09/09
Relevance Score: 66%
EFNA1 ligand and its receptor EphA2: Potential biomarkers for hepatocellular carcinoma
International Journal of Cancer, 11/09/09
Relevance Score: 65%
Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas
Lung Cancer, 11/06/09
Relevance Score: 65%
Today in Nose...keeping you current
Receive free subspecialty "5-minute updates" via email
Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis
Allergy and Asthma Proceedings, 12/17/09
Investigational drugs for allergic rhinitis
Expert Opinion on Investigational Drugs, 12/17/09
Single dose of preoperative analgesia with gabapentin (600 mg) is safe and effective in monitored anesthesia care for nasal surgery
European Archives of Oto-Rhino-Laryngology, 12/16/09